Immune Checkpoint Inhibitors in Locally Advanced, Unresectable, and Metastatic Upper Gastrointestinal Malignancies

被引：0
|
作者：
Heather Katz
Layana Biglow
Mohamed Alsharedi
机构：
[1] Marshall University,Department of Hematology/Oncology, Joan C. Edwards School of Medicine
[2] Marshall University,Department of Internal Medicine, Joan C. Edwards School of Medicine
[3] Marshall University,Division of Hematology and Oncology, Joan C. Edwards School of Medicine
来源：
Journal of Gastrointestinal Cancer | 2020年 / 51卷
关键词：
Esophageal cancer; GEJ; Gastric cancer; Immune therapy; Checkpoint inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：611 / 619
页数：8
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors in Metastatic Bladder and Other Solid Malignancies: How Long is Enough?
    Kumar, Vivek
    Wei, Xiao X.
    BLADDER CANCER, 2023, 9 (03) : 201 - 210
  • [32] Immune-checkpoint inhibitors in pituitary malignancies
    Di Nunno, Vincenzo
    Franceschi, Enrico
    Tosoni, Alicia
    Gatto, Lidia
    Maggio, Ilaria
    Lodi, Raffaele
    Bartolini, Stefania
    Brandes, Alba A.
    ANTI-CANCER DRUGS, 2022, 33 (01) : E28 - E35
  • [33] Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies
    Ring, Kari L.
    Pakish, Janelle
    Jazaeri, Amir A.
    CANCER JOURNAL, 2016, 22 (02): : 101 - 107
  • [34] Immune checkpoint inhibitors to treat cutaneous malignancies
    Barrios, Dulce M.
    Do, Mytrang H.
    Phillips, Gregory S.
    Postow, Michael A.
    Akaike, Tomoko
    Nghiem, Paul
    Lacouture, Mario E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1239 - 1253
  • [35] The efficacy of immune checkpoint inhibitors in thoracic malignancies
    Remon, Jordi
    Facchinetti, Francesco
    Besse, Benjamin
    EUROPEAN RESPIRATORY REVIEW, 2021, 30 (162):
  • [36] Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
    Metro, Giulio
    Signorelli, Diego
    Pizzutilo, Elio G.
    Giannetta, Laura
    Cerea, Giulio
    Garaffa, Miriam
    Friedlaender, Alex
    Addeo, Alfredo
    Mandarano, Martina
    Bellezza, Guido
    Roila, Fausto
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (09) : 2972 - 2980
  • [37] Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies
    Takanori Ito
    Masatoshi Ishigami
    Takafumi Yamamoto
    Kazuyuki Mizuno
    Kenta Yamamoto
    Norihiro Imai
    Yoji Ishizu
    Takashi Honda
    Hiroki Kawashima
    Satoshi Yasuda
    Hidenori Toyoda
    Kenji Yokota
    Tetsunari Hase
    Naoki Nishio
    Osamu Maeda
    Masashi Kato
    Naozumi Hashimoto
    Hideharu Hibi
    Yasuhiro Kodera
    Michihiko Sone
    Yuichi Ando
    Masashi Akiyama
    Yoshie Shimoyama
    Mitsuhiro Fujishiro
    Hepatology International, 2021, 15 : 1278 - 1287
  • [38] Gemcitabine for unresectable, locally advanced or metastatic bladder cancer
    Shelly, M.
    Cleves, A.
    Wilt, T. J.
    Mason, M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (04):
  • [39] Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies
    Ito, Takanori
    Ishigami, Masatoshi
    Yamamoto, Takafumi
    Mizuno, Kazuyuki
    Yamamoto, Kenta
    Imai, Norihiro
    Ishizu, Yoji
    Honda, Takashi
    Kawashima, Hiroki
    Yasuda, Satoshi
    Toyoda, Hidenori
    Yokota, Kenji
    Hase, Tetsunari
    Nishio, Naoki
    Maeda, Osamu
    Kato, Masashi
    Hashimoto, Naozumi
    Hibi, Hideharu
    Kodera, Yasuhiro
    Sone, Michihiko
    Ando, Yuichi
    Akiyama, Masashi
    Shimoyama, Yoshie
    Fujishiro, Mitsuhiro
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1278 - 1287
  • [40] Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
    Zhao, Xiao-Han
    Gao, Hong-Mei
    Wen, Jing-Yuan
    Wang, He-Song
    Wu, Luan-Ying
    Song, Chun-Yang
    Deng, Wen-Zhao
    Zhu, Shu-Chai
    Shen, Wen-Bin
    DISCOVER ONCOLOGY, 2023, 14 (01)
12345